Summary
Researchers at the University of California, San Francisco ran an online survey of 41 trans men who had become pregnant and given birth after transitioning. They asked about hormone use, fertility, pregnancy care and birth. About six in ten had taken testosterone before the pregnancy, most used their own eggs, half had a doctor for pregnancy care, and most gave birth in hospital. People described health workers who knew little about their situation and wished for better support. The authors concluded that trans men can and do get pregnant after transition and that services should adapt. It was one of the first studies of its kind and is often cited to show fertility can return after stopping testosterone. But it only asked people who did get pregnant, so it cannot say how often testosterone users stay fertile. All answers came from a small, self-selected online group.
Key findings
- 41 selvbeskrevne transmenn som hadde vært gravide og født barn etter overgang fylte ut en nettundersøkelse mellom mars og desember 2013.
- Før graviditeten hadde 61 % (25 av 41) brukt testosteron. Å ha tatt hormoner var ikke et krav for å delta.
- I gjennomsnitt var de 28 år da de ble gravide, og 88 % (36) av svangerskapene brukte personens egne egg.
- Halvparten fikk svangerskapsomsorg av en lege, og 78 % fødte på sykehus.
- I de skriftlige svarene sa folk at helsearbeidere visste lite om behovene til gravide transmenn, og at de ønsket ressurser som kunne støtte dem.
- Fordi bare personer som faktisk ble gravide ble spurt, viser studien at graviditet etter testosteron er mulig, men kan ikke si hvor ofte fruktbarheten kommer tilbake etter testosteron.
Abstract
OBJECTIVE: To conduct a cross-sectional study of transgender men who had been pregnant and delivered after transitioning from female-to-male gender to help guide practice and further investigation.
MATERIALS AND METHODS: We administered a web-based survey from March to December 2013 to inquire about demographics, hormone use, fertility, pregnancy experience, and birth outcomes. Participants were not required to have been on hormone therapy to be eligible. We used a mixed-methods approach to evaluate the quantitative and qualitative data.
RESULTS: Forty-one self-described transgender men completed the survey. Before pregnancy, 61% (n=25) had used testosterone. Mean age at conception was 28 years with a standard deviation of 6.8 years. Eighty-eight percent of oocytes (n=36) came from participants' own ovaries. Half of the participants received prenatal care from a physician and 78% delivered in a hospital. Qualitative themes included low levels of health care provider awareness and knowledge about the unique needs of pregnant transgender men as well as a desire for resources to support transgender men through their pregnancy.
CONCLUSION: Transgender men are achieving pregnancy after having socially, medically, or both transitioned. Themes from this study can be used to develop transgender-appropriate services and interventions that may improve the health and health care experiences of transgender men.
Conclusion
Transgender men are achieving pregnancy after having socially, medically, or both transitioned. Themes from this study can be used to develop transgender-appropriate services and interventions that may improve the health and health care experiences of transgender men.